Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sanchez MJS et al. – Conversion from AZA to EC–MPA to optimize immunosuppression seemed to be safe, with no complications in 85% of cases, as well as effective, achieving improved long–term renal function protection. These results suggested a greater protective immunological effect by switching from AZA to EC–MPA.

Related Articles

Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09    Relevance Score: 94%

Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09    Relevance Score: 94%

Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 94%

Factors influencing liver transplant length of stay at two large-volume transplant centers
Liver Transplantation, 11/03/09    Relevance Score: 93%

Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 93%

Today in Pharmacology/kinetics...keeping you current

Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09

Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
Transplantation Proceedings, 12/18/09

Low-Dose Dopamine in Kidney Transplantation
Transplantation Proceedings, 12/18/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address